Patents by Inventor Pierre L. Coursaget

Pierre L. Coursaget has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HPV particles and uses thereof
    Patent number: 10688172
    Abstract: The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.
    Type: Grant
    Filed: November 29, 2018
    Date of Patent: June 23, 2020
    Assignees: INSERM (Institut National de la Santé et de la Recherche Médicale), Aura Biosciences, Inc.
    Inventors: Pierre L. Coursaget, Antoine A. Touźe, Maxime J. J. Fleury, Nicolas Combelas, Elisabet de los Pinos
  • HPV PARTICLES AND USES THEREOF
    Publication number: 20190142925
    Abstract: The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.
    Type: Application
    Filed: November 29, 2018
    Publication date: May 16, 2019
    Applicants: INSERM (Institut National de la Santé et de la Recherche Médicale), Aura Biosciences, Inc.
    Inventors: Pierre L. Coursaget, Antoine A. Touzé, Maxime J.J. Fleury, Nicolas Combelas, Elisabet de los Pinos
  • HPV particles and uses thereof
    Patent number: 10179168
    Abstract: The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: January 15, 2019
    Assignees: INSERM (Institut National de la Santé et de la Recherche Médicale, Aura Biosciences, Inc.
    Inventors: Pierre L. Coursaget, Antoine A. Touzé, Maxime J. J. Fleury, Nicolas Combelas, Elisabet de los Pinos
  • HPV PARTICLES AND USES THEREOF
    Publication number: 20170368162
    Abstract: The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.
    Type: Application
    Filed: June 28, 2017
    Publication date: December 28, 2017
    Applicants: INSERM (Institut National de la Sante et de la Recherche Medicale), Aura Biosciences, Inc.
    Inventors: Pierre L. Coursaget, Antoine A. Touze, Maxime J.J. Fleury, Nicolas Combelas, Elisabet de los Pinos
  • HPV particles and uses thereof
    Patent number: 9724404
    Abstract: The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.
    Type: Grant
    Filed: July 24, 2009
    Date of Patent: August 8, 2017
    Assignees: INSERM (Institut National de la Santé et de la Recherche Médicale), Aura Biosciences, Inc.
    Inventors: Pierre L. Coursaget, Antoine A. Touzé, Maxime J. J. Fleury, Nicolas Combelas, Elisabet de los Pinos
  • HPV PARTICLES AND USES THEREOF
    Publication number: 20120171290
    Abstract: The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.
    Type: Application
    Filed: July 24, 2009
    Publication date: July 5, 2012
    Inventors: Pierre L. Coursaget, Antoine A. Touzé, Maxime J.J. Fleury, Nicolas Combelas, Elisabet de los Pinos